Latest Hemolytic disease of the newborn Stories
NEW YORK, April 6, 2011 /PRNewswire/ -- KellBenx, a biotechnology company focused on the development of non-invasive prenatal diagnosis (NIPD) of genetic and inherited disorders, announced today that it has signed an exclusive agreement with AdnaGen, a wholly-owned subsidiary of Alere, Inc., to license specific antibodies.
Blood group incompatibility between Henry VIII and his wives could have driven the Tudor king's reproductive woes.
NEW YORK, Oct.
RhoGAM(R) Brand Hailed as One of the Top Achievements in 50 Years of Women's Health RARITAN, N.J., Feb.
- A poem in which the author retracts something said in an earlier poem.